Abstract
References
Articles referenced by this article (87)
CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome.
Science, (5097):990-993 1993
MED: 7679801
The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome.
Cell, (2):291-300 1993
MED: 7678782
Long-term human B cell lines dependent on interleukin-4 and antibody to CD40.
Science, (4989):70-72 1991
MED: 1702555
Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated MHC class II molecules
1993
Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major.
Science, (5069):539-542 1992
MED: 1636090
Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.
Nature, (6432):33-39 1993
MED: 8316295
CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes.
Science, (5053):105-107 1992
MED: 1373518
Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4.
Cell, (7):1093-1102 1992
MED: 1335364
Show 10 more references (10 of 87)
Citations & impact
Impact metrics
Article citations
Gene engineered exosome reverses T cell exhaustion in cancer immunotherapy.
Bioact Mater, 34:466-481, 13 Jan 2024
Cited by: 2 articles | PMID: 38292412 | PMCID: PMC10825617
Antitumor Immune Responses in B2M-Deficient Cancers.
Cancer Immunol Res, 11(12):1642-1655, 01 Dec 2023
Cited by: 2 articles | PMID: 37801341
Radiotherapy combined with nano-biomaterials for cancer radio-immunotherapy.
J Nanobiotechnology, 21(1):395, 30 Oct 2023
Cited by: 4 articles | PMID: 37899463 | PMCID: PMC10614396
Review Free full text in Europe PMC
Activation of autophagy by in situ Zn2+ chelation reaction for enhanced tumor chemoimmunotherapy.
Bioact Mater, 29:116-131, 05 Jul 2023
Cited by: 4 articles | PMID: 37456582
Potential Promises and Perils of Human Biological Treatments for Immunotherapy in Veterinary Oncology.
Vet Sci, 10(5):336, 09 May 2023
Cited by: 1 article | PMID: 37235419 | PMCID: PMC10224056
Review Free full text in Europe PMC
Go to all (462) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
J Immunol, 159(12):5956-5963, 01 Dec 1997
Cited by: 149 articles | PMID: 9550393
Role of IL-6, IL-1, and CD28 signaling in responses of mouse CD4+ T cells to immobilized anti-TCR monoclonal antibody.
J Immunol, 152(4):1618-1628, 01 Feb 1994
Cited by: 20 articles | PMID: 7907103
Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimum response.
J Immunol, 155(1):45-57, 01 Jul 1995
Cited by: 165 articles | PMID: 7541426
Expression and functional significance of CTLA-4, a negative regulator of T cell activation.
Arch Immunol Ther Exp (Warsz), 49(1):39-46, 01 Jan 2001
Cited by: 19 articles | PMID: 11266089
Review
Funding
Funders who supported this work.
NCI NIH HHS (1)
Grant ID: CA-38350
NIAID NIH HHS (2)
Grant ID: AI-14579
Grant ID: AI-26810